Cell cycle inhibition, apoptosis, and molecular docking studies of the novel anticancer bioactive 1,2,4-triazole derivatives
作者:Javad Ghanaat、Mohammad A. Khalilzadeh、Daryoush Zareyee、Mohammadreza Shokouhimehr、Rajender S. Varma
DOI:10.1007/s11224-019-01453-3
日期:2020.4
Several 3-alkylsulfanyl-1,2,4-triazole derivatives were synthesized and their relevant structures confirmed based on their elemental analysis and nuclear magnetic resonance. The anticancer activity of all the derivatives was evaluated for A549, MCF7, and SKOV3 cell lines by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay wherein compound 5e demonstrated significant anti-proliferative activities against all cell lines whereas 5b and 5e showed efficient anti-proliferative actions in SKOV3 cell line having half maximal inhibitory concentration (IC50) values of 0.81 and 0.53 μM, respectively. Furthermore, compound 5e was found to drive remarkable cell cycle arrest at the G2/M phase for SKOV3 cell lines in a concentration-dependent behavior. Molecular docking studies performed with these derivatives validated them as appropriate candidates for further studies of their potential anticancer activity.
研究人员合成了几种 3-烷基硫基-1,2,4-三唑衍生物,并通过元素分析和核磁共振确认了它们的相关结构。通过 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑溴化物检测法评估了所有衍生物对 A549、MCF7 和 SKOV3 细胞系的抗癌活性,其中化合物 5e 对所有细胞系都具有显著的抗增殖活性,而 5b 和 5e 对 SKOV3 细胞系具有高效的抗增殖作用,其半最大抑制浓度 (IC50) 值分别为 0.81 和 0.53 μM。此外,还发现化合物 5e 能使 SKOV3 细胞株的细胞周期显著停滞在 G2/M 期,其行为与浓度有关。对这些衍生物进行的分子对接研究证实,它们是进一步研究其潜在抗癌活性的合适候选化合物。